{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:52:04Z","timestamp":1779335524380,"version":"3.51.4"},"reference-count":115,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020027","name":"Dr. Rolf M. Schwiete Stiftung","doi-asserted-by":"crossref","award":["2024-021"],"award-info":[{"award-number":["2024-021"]}],"id":[{"id":"10.13039\/501100020027","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Glycosaminoglycans (GAGs) are essential regulators of numerous biological processes through their interactions with growth factors, chemokines, cytokines, and enzymes. Their structural diversity and heterogeneity, however, limit reproducibility and translational use, as native GAGs are typically obtained from animal-derived sources with notable batch-to-batch variability. To overcome these challenges, a wide range of GAG mimetics has been developed with the aim of replicating or modulating the biological functions of native GAGs while offering improved structural definition, accessibility, and therapeutic potential. Polysaccharide-based GAG mimetics, including derivatives of heparan sulfate, hyaluronan, dextran, and other natural glycans, represent one major strategy, whereas non-saccharide-based mimetics provide alternative scaffolds with enhanced stability and selectivity. Both approaches have yielded compounds that serve as valuable tools for dissecting GAG\/protein interactions and as candidates for therapeutic development. Biomedical applications of GAG mimetics span diverse areas such as cancer, cardiovascular and inflammatory diseases, bone and cartilage regeneration, wound healing, and infectious diseases. This mini-review summarizes key developments in the design and synthesis of GAG mimetics, highlights their potential biomedical applications, and discusses current challenges and future perspectives in advancing them toward clinical translation.<\/jats:p>","DOI":"10.3390\/biom15111518","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:47:19Z","timestamp":1761652039000},"page":"1518","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["From Native Glycosaminoglycans to Mimetics: Design, Mechanisms, and Biomedical Applications"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2942-331X","authenticated-orcid":false,"given":"Fabian","family":"Junker","sequence":"first","affiliation":[{"name":"Institute of Biophysics, Center of Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421 Homburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-752X","authenticated-orcid":false,"given":"Sandra","family":"Rother","sequence":"additional","affiliation":[{"name":"Institute of Biophysics, Center of Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, 66421 Homburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"ref_1","first-page":"e23","article-title":"Medical Application of Glycosaminoglycans: A Review","volume":"12","author":"Zhou","year":"2017","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev-biochem-060713-035314","article-title":"Demystifying Heparan Sulfate-Protein Interactions","volume":"83","author":"Xu","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.biochem.71.110601.135458","article-title":"Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate","volume":"71","author":"Esko","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Pessentheiner, A.R., Ducasa, G.M., and Gordts, P.L.S.M. (2020). Proteoglycans in Obesity-Associated Metabolic Dysfunction and Meta-Inflammation. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00769"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"122106","DOI":"10.1016\/j.carbpol.2024.122106","article-title":"Glycosaminoglycan Microarrays for Studying Glycosaminoglycan-Protein Systems","volume":"335","author":"Chittum","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Portillo, G., Li, D.R., Goyal, Y., Rowan, N., Al-Horani, B.G., Anbalagan, R.A., Heparin, M., Gatica Portillo, D.R., Li, Y., and Goyal, N. (2025). Heparin, Heparin-like Molecules, and Heparin Mimetics in Breast Cancer: A Concise Review. Biomolecules, 15.","DOI":"10.3390\/biom15071034"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Shi, D., Sheng, A., and Chi, L. (2021). Glycosaminoglycan-Protein Interactions and Their Roles in Human Disease. Front. Mol. Biosci., 8.","DOI":"10.3389\/fmolb.2021.639666"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1369\/0022155420946403","article-title":"Glycosaminoglycan-Protein Interactions: The First Draft of the Glycosaminoglycan Interactome","volume":"69","author":"Vallet","year":"2021","journal-title":"J. Histochem. Cytochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2312154","DOI":"10.1002\/adma.202312154","article-title":"Sweet but Challenging: Tackling the Complexity of GAGs with Engineered Tailor-Made Biomaterials","volume":"36","author":"Picart","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1877-1173(10)93001-9","article-title":"Glycosaminoglycan (GAG) Biosynthesis and GAG-Binding Proteins","volume":"93","author":"Zhang","year":"2010","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"a004952","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan Sulfate Proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ajcp\/89.1.19","article-title":"The Variations between Heparin Sensitivity of Different Lots of Activated Partial Thromboplastin Time Reagent Produced by the Same Manufacturer","volume":"89","author":"Shojania","year":"1988","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.1021\/acs.chemrev.6b00010","article-title":"Chemical Synthesis of Glycosaminoglycans","volume":"116","author":"Mende","year":"2016","journal-title":"Chem. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/glycob\/cwt016","article-title":"Chemoenzymatic Synthesis of Glycosaminoglycans: Re-Creating, Re-Modeling and Re-Designing Nature\u2019s Longest or Most Complex Carbohydrate Chains","volume":"23","author":"Deangelis","year":"2013","journal-title":"Glycobiology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00253-011-3801-6","article-title":"Glycosaminoglycan Polysaccharide Biosynthesis and Production: Today and Tomorrow","volume":"94","author":"DeAngelis","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1021\/acs.jmedchem.2c01511","article-title":"Designing Synthetic, Sulfated Glycosaminoglycan Mimetics That Are Orally Bioavailable and Exhibiting In Vivo Anticancer Activity","volume":"66","author":"Morla","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.2004.tb00127.x","article-title":"Phosphomannopentaose Sulfate (PI-88): Heparan Sulfate Mimetic with Clinical Potential in Multiple Vascular Pathologies","volume":"22","author":"Khachigian","year":"2004","journal-title":"Cardiovasc. Drug Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.RES.0000071345.76095.07","article-title":"Blockade of Vascular Smooth Muscle Cell Proliferation and Intimal Thickening after Balloon Injury by the Sulfated Oligosaccharide PI-88: Phosphomannopentaose Sulfate Directly Binds FGF-2, Blocks Cellular Signaling, and Inhibits Proliferation","volume":"92","author":"Francis","year":"2003","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Morla, S. (2019). Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081963"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-3-030-34521-1_19","article-title":"PI-88 and Related Heparan Sulfate Mimetics","volume":"1221","author":"Chhabra","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1039\/C5OB02513C","article-title":"Synthesis, Radiolabeling with Fluorine-18 and Preliminary in Vivo Evaluation of a Heparan Sulphate Mimetic as Potent Angiogenesis and Heparanase Inhibitor for Cancer Applications","volume":"14","author":"Kuhnast","year":"2016","journal-title":"Org. Biomol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.bcp.2004.11.021","article-title":"Effect of an Oversulfated Exopolysaccharide on Angiogenesis Induced by Fibroblast Growth Factor-2 or Vascular Endothelial Growth Factor in Vitro","volume":"69","author":"Matou","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1007\/s00253-010-2677-1","article-title":"Production of Chondroitin Sulfate and Chondroitin","volume":"87","author":"Schiraldi","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1002\/anie.201101142","article-title":"A Microbiological\u2013Chemical Strategy to Produce Chondroitin Sulfate A,C","volume":"50","author":"Bedini","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.carbpol.2018.02.072","article-title":"Sulfation Degree Not Origin of Chondroitin Sulfate Derivatives Modulates Keratinocyte Response","volume":"191","author":"Corsuto","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41467-021-21692-5","article-title":"Complete Biosynthesis of a Sulfated Chondroitin in Escherichia Coli","volume":"12","author":"Badri","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e00710","DOI":"10.1016\/j.btre.2022.e00710","article-title":"Heterologous Production of Chondroitin","volume":"33","author":"Couto","year":"2022","journal-title":"Biotechnol. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11338","DOI":"10.1002\/chem.201701890","article-title":"Glycodendrimers as Chondroitin Sulfate Mimetics: Synthesis and Binding to Growth Factor Midkine","volume":"23","author":"Reina","year":"2017","journal-title":"Chemistry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"12395","DOI":"10.1002\/chem.202101674","article-title":"Midkine Interaction with Chondroitin Sulfate Model Synthetic Tetrasaccharides and Their Mimetics: The Role of Aromatic Interactions","volume":"27","author":"Maza","year":"2021","journal-title":"Chem.\u2014A Eur. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10898","DOI":"10.1021\/ja4027727","article-title":"Tunable Heparan Sulfate Mimetics for Modulating Chemokine Activity","volume":"135","author":"Sheng","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hintze, V., Schnabelrauch, M., and Rother, S. (2022). Chemical Modification of Hyaluronan and Their Biomedical Applications. Front. Chem., 10.","DOI":"10.3389\/fchem.2022.830671"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"H41","DOI":"10.1002\/adma.201003963","article-title":"Hyaluronic Acid Hydrogels for Biomedical Applications","volume":"23","author":"Burdick","year":"2011","journal-title":"Adv. Mater."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.actbio.2012.03.021","article-title":"Sulfated Hyaluronan and Chondroitin Sulfate Derivatives Interact Differently with Human Transforming Growth Factor-\u03921 (TGF-\u03921)","volume":"8","author":"Hintze","year":"2012","journal-title":"Acta Biomater."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1021\/bm5006855","article-title":"Sulfated Glycosaminoglycans Exploit the Conformational Plasticity of Bone Morphogenetic Protein 2 (BMP-2) and Alter the Interaction Pro Fi Le with Its Receptor","volume":"15","author":"Hintze","year":"2014","journal-title":"Biomacromolecules"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1021\/bm9008827","article-title":"Modifications of Hyaluronan Influence the Interaction with Human Bone Morphogenetic Protein-4 (HBMP-4)","volume":"10","author":"Hintze","year":"2009","journal-title":"Biomacromolecules"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"18143","DOI":"10.1038\/s41598-019-54211-0","article-title":"Dual Action of Sulfated Hyaluronan on Angiogenic Processes in Relation to Vascular Endothelial Growth Factor-A","volume":"9","author":"Koehler","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.actbio.2019.01.029","article-title":"Hyaluronan\/Collagen Hydrogels Containing Sulfated Hyaluronan Improve Wound Healing by Sustained Release of Heparin-Binding EGF-like Growth Factor","volume":"86","author":"Rother","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.actbio.2016.08.030","article-title":"Structural and Functional Insights into the Interaction of Sulfated Glycosaminoglycans with Tissue Inhibitor of Metalloproteinase-3\u2014A Possible Regulatory Role on Extracellular Matrix Homeostasis","volume":"45","author":"Rother","year":"2016","journal-title":"Acta Biomater."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1016\/j.biomaterials.2013.06.053","article-title":"The Promotion of Osteoclastogenesis by Sulfated Hyaluronan through Interference with Osteoprotegerin and Receptor Activator of NF-\u039aB Ligand\/Osteoprotegerin Complex Formation","volume":"34","author":"Kraemer","year":"2013","journal-title":"Biomaterials"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.biomaterials.2015.07.021","article-title":"Structural and Functional Insights into Sclerostin-Glycosaminoglycan Interactions in Bone","volume":"67","author":"Samsonov","year":"2015","journal-title":"Biomaterials"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Shi, J., Kanoya, R., Tani, Y., Ishikawa, S., Maeda, R., Suzuki, S., Kawanami, F., Miyagawa, N., Takahashi, K., and Oku, T. (2022). Sulfated Hyaluronan Binds to Heparanase and Blocks Its Enzymatic and Cellular Actions in Carcinoma Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23095055"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/acscentsci.1c01293","article-title":"Synthetic Heparan Sulfate Mimetic Pixatimod (PG545) Potently Inhibits SARS-CoV-2 by Disrupting the Spike\u2013ACE2 Interaction","volume":"8","author":"Guimond","year":"2022","journal-title":"ACS Cent. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/glycob\/cwp130","article-title":"Glycosaminoglycan Mimetics Inhibit SDF-1\/CXCL12-Mediated Migration and Invasion of Human Hepatoma Cells","volume":"19","author":"Friand","year":"2009","journal-title":"Glycobiology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9853","DOI":"10.1128\/JVI.01276-15","article-title":"Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake","volume":"89","author":"Wolf","year":"2015","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Ramasundaram, S., Saravanakumar, G., Sobha, S., and Oh, T.H. (2022). Dextran Sulfate Nanocarriers: Design, Strategies and Biomedical Applications. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010355"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10719-016-9744-5","article-title":"RGTA\u00ae or ReGeneraTing Agents Mimic Heparan Sulfate in Regenerative Medicine: From Concept to Curing Patients","volume":"34","author":"Barritault","year":"2017","journal-title":"Glycoconj. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/bm500602w","article-title":"Heparin-like Properties of Sulfated Alginates with Defined Sequences and Sulfation Degrees","volume":"15","author":"Arlov","year":"2014","journal-title":"Biomacromolecules"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1021\/acs.biomac.5b01125","article-title":"The Impact of Chain Length and Flexibility in the Interaction between Sulfated Alginates and HGF and FGF-2","volume":"16","author":"Arlov","year":"2015","journal-title":"Biomacromolecules"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1023\/A:1006940632184","article-title":"Structure-Function Relations of Heparin-Mimetic Sulfated Xylan Oligosaccharides: Inhibition of Human Immunodeficiency Virus-1 Infectivity in Vitro","volume":"15","author":"Stone","year":"1998","journal-title":"Glycoconj. J."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Zayed, A., Avila-Peltroche, J., El-Aasr, M., and Ulber, R. (2022). Sulfated Galactofucans: An Outstanding Class of Fucoidans with Promising Bioactivities. Mar. Drugs, 20.","DOI":"10.3390\/md20070412"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"112105","DOI":"10.1016\/j.colsurfb.2021.112105","article-title":"Sulfated Alginate\/Polycaprolactone Double-Emulsion Nanoparticles for Enhanced Delivery of Heparin-Binding Growth Factors in Wound Healing Applications","volume":"208","author":"Maatouk","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.carbpol.2016.04.092","article-title":"Sulfated Levan from Halomonas Smyrnensis as a Bioactive, Heparin-Mimetic Glycan for Cardiac Tissue Engineering Applications","volume":"149","author":"Erginer","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"213020","DOI":"10.1016\/j.bioadv.2022.213020","article-title":"Regioselective Sulfated Chitosan Produces a Biocompatible and Antibacterial Wound Dressing with Low Inflammatory Response","volume":"139","author":"Karimi","year":"2022","journal-title":"Biomater. Adv."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1021\/acsabm.5c01206","article-title":"Trinary Dressing Material Formed between Polysaccharides and Gold Nanoparticles for Synergistic Wound Disinfection and Repair","volume":"8","author":"Gan","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1016\/j.biomaterials.2008.04.025","article-title":"The Effect of Sulfation of Alginate Hydrogels on the Specific Binding and Controlled Release of Heparin-Binding Proteins","volume":"29","author":"Freeman","year":"2008","journal-title":"Biomaterials"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e2101048","DOI":"10.1002\/adhm.202101048","article-title":"Sulfated Alginate Hydrogels Prolong the Therapeutic Potential of MSC Spheroids by Sequestering the Secretome","volume":"10","author":"Casella","year":"2021","journal-title":"Adv. Heal. Mater."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9914","DOI":"10.1038\/s41598-021-89330-0","article-title":"Formulation and Evaluation of Injectable Dextran Sulfate Sodium Nanoparticles as a Potent Antibacterial Agent","volume":"11","author":"Madkhali","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.2174\/0929867325666181120101147","article-title":"Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies","volume":"27","author":"Afosah","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8842","DOI":"10.1074\/jbc.M410769200","article-title":"Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin\/Heparan Sulfate Binding Specificity of Proteins","volume":"280","author":"Freeman","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Zhang, Y., and Cui, L. (2023). Discovery and Development of Small-Molecule Heparanase Inhibitors. Bioorg. Med. Chem., 90.","DOI":"10.1016\/j.bmc.2023.117335"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1016\/j.bmcl.2012.04.014","article-title":"Discovery of Novel Sulfonated Small Molecules That Inhibit Vascular Tube Formation","volume":"22","author":"Raman","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/cb500402f","article-title":"Synthetic, Non-Saccharide, Glycosaminoglycan Mimetics Selectively Target Colon Cancer Stem Cells","volume":"9","author":"Patel","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1535-7163.MCT-18-0104","article-title":"A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via P38 MAP Kinase Activation","volume":"18","author":"Boothello","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1039\/C8SC02303D","article-title":"Facile Saccharide-Free Mimetics That Recapitulate Key Features of Glycosaminoglycan Sulfation Patterns","volume":"9","author":"Lim","year":"2018","journal-title":"Chem. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.0805862105","article-title":"Surfen, a Small Molecule Antagonist of Heparan Sulfate","volume":"105","author":"Schuksz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Mohamed, S., and Coombe, D.R. (2017). Heparin Mimetics: Their Therapeutic Potential. Pharmaceuticals, 10.","DOI":"10.3390\/ph10040078"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lanzi, C., and Cassinelli, G. (2018). Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity. Molecules, 23.","DOI":"10.3390\/molecules23112915"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/19336918.2020.1767489","article-title":"The Anti-Cancer Properties of Heparin and Its Derivatives: A Review and Prospect","volume":"14","author":"Ma","year":"2020","journal-title":"Cell Adhes. Migr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00109-011-0843-2","article-title":"Regenerative Potential of Glycosaminoglycans for Skin and Bone","volume":"90","author":"Salbach","year":"2012","journal-title":"J. Mol. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1515\/hsz-2021-0174","article-title":"New Insights into the Role of Glycosaminoglycans in the Endosteal Bone Microenvironment","volume":"402","author":"Rauner","year":"2021","journal-title":"Biol. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1515\/hsz-2021-0176","article-title":"Collagen\/Glycosaminoglycan-Based Matrices for Controlling Skin Cell Responses","volume":"402","author":"Anderegg","year":"2021","journal-title":"Biol. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10856-015-5563-7","article-title":"Glycosaminoglycan Derivatives: Promising Candidates for the Design of Functional Biomaterials","volume":"26","author":"Scharnweber","year":"2015","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1016\/j.actbio.2013.04.023","article-title":"Artificial Extracellular Matrix Composed of Collagen I and Highly Sulfated Hyaluronan Interferes with TGF\u03b21 Signaling and Prevents TGF\u03b21-Induced Myofibroblast Differentiation","volume":"9","author":"Samsonov","year":"2013","journal-title":"Acta Biomater."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Syanda, A.M., Kringstad, V.I., Blackford, S.J.I., Kjesbu, J.S., Ng, S.S., Ma, L., Xiao, F., Coron, A.E., Rokstad, A.M.A., and Modi, S. (2022). Sulfated Alginate Reduces Pericapsular Fibrotic Overgrowth on Encapsulated CGMP-Compliant HPSC-Hepatocytes in Mice. Front. Bioeng. Biotechnol., 9.","DOI":"10.3389\/fbioe.2021.816542"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"8173","DOI":"10.1073\/pnas.1319870111","article-title":"Synthetic Di-Sulfated Iduronic Acid Attenuates Asthmatic Response by Blocking T-Cell Recruitment to Inflammatory Sites","volume":"111","author":"Nonaka","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Koliesnik, I.O., Kuipers, H.F., Medina, C.O., Zihsler, S., Liu, D., Van Belleghem, J.D., and Bollyky, P.L. (2020). The Heparan Sulfate Mimetic PG545 Modulates T Cell Responses and Prevents Delayed-Type Hypersensitivity. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.00132"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1158\/1535-7163.MCT-07-0114","article-title":"Glycosaminoglycans and Their Synthetic Mimetics Inhibit RANTES-Induced Migration and Invasion of Human Hepatoma Cells","volume":"6","author":"Sutton","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"al Matari, N., Deeb, G., Mshiek, H., Sinjab, A., Kadara, H., Abou-Kheir, W., and Mhanna, R. (2020). Anti-Tumor Effects of Biomimetic Sulfated Glycosaminoglycans on Lung Adenocarcinoma Cells in 2D and 3D In Vitro Models. Molecules, 25.","DOI":"10.3390\/molecules25112595"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1021\/jm201708h","article-title":"Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and Metastasis","volume":"55","author":"Ferro","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e006136","DOI":"10.1136\/jitc-2022-006136","article-title":"Phase Ib Open-Label, Multicenter Study of Pixatimod, an Activator of TLR9, in Combination with Nivolumab in Subjects with Microsatellite-Stable Metastatic Colorectal Cancer, Metastatic Pancreatic Ductal Adenocarcinoma and Other Solid Tumors","volume":"11","author":"Lemech","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.2337\/db19-0725","article-title":"Dextran Sulfate Protects Pancreatic \u03b2-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes","volume":"69","author":"Lu","year":"2020","journal-title":"Diabetes"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.scr.2014.03.001","article-title":"Glycosaminoglycan Mimetic Improves Enrichment and Cell Functions of Human Endothelial Progenitor Cell Colonies","volume":"12","author":"Chevalier","year":"2014","journal-title":"Stem Cell Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2016.04.013","article-title":"Sulfated Hyaluronan Improves Bone Regeneration of Diabetic Rats by Binding Sclerostin and Enhancing Osteoblast Function","volume":"96","author":"Picke","year":"2016","journal-title":"Biomaterials"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.scr.2011.09.005","article-title":"Glycosaminoglycans Mimetics Potentiate the Clonogenicity, Proliferation, Migration and Differentiation Properties of Rat Mesenchymal Stem Cells","volume":"8","author":"Frescaline","year":"2012","journal-title":"Stem Cell Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1021\/acs.biomac.6b00980","article-title":"Sulfated Hyaluronan Alters the Interaction Profile of TIMP-3 with the Endocytic Receptor LRP-1 Clusters II and IV and Increases the Extracellular TIMP-3 Level of Human Bone Marrow Stromal Cells","volume":"17","author":"Rother","year":"2016","journal-title":"Biomacromolecules"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1742-481X.2010.00748.x","article-title":"Regenerating Matrix-Based Therapy for Chronic Wound Healing: A Prospective within-Subject Pilot Study","volume":"8","author":"Groah","year":"2011","journal-title":"Int. Wound J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e592","DOI":"10.1002\/term.2331","article-title":"Investigating Cellulose Derived Glycosaminoglycan Mimetic Scaffolds for Cartilage Tissue Engineering Applications","volume":"12","author":"Huang","year":"2018","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.actbio.2019.03.024","article-title":"Investigation of Glycosaminoglycan Mimetic Scaffolds for Neurite Growth","volume":"90","author":"Menezes","year":"2019","journal-title":"Acta Biomater."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1182\/blood-2009-12-260513","article-title":"GMI-1070, a Novel Pan-Selectin Antagonist, Reverses Acute Vascular Occlusions in Sickle Cell Mice","volume":"116","author":"Chang","year":"2010","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/blood-2014-06-583351","article-title":"Randomized Phase 2 Study of GMI-1070 in SCD: Reduction in Time to Resolution of Vaso-Occlusive Events and Decreased Opioid Use","volume":"125","author":"Telen","year":"2015","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood.2022015797","article-title":"A Randomized Clinical Trial of the Efficacy and Safety of Rivipansel for Sickle Cell Vaso-Occlusive Crisis","volume":"141","author":"Dampier","year":"2023","journal-title":"Blood"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e2203167119","DOI":"10.1073\/pnas.2203167119","article-title":"Mechanism-Based Heparanase Inhibitors Reduce Cancer Metastasis in Vivo","volume":"119","author":"Armstrong","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1021\/acsomega.7b01662","article-title":"Structure-Activity Relationships of GAG Mimetic-Functionalized Mesoporous Silica Nanoparticles and Evaluation of Acyclovir-Loaded Antiviral Nanoparticles with Dual Mechanisms of Action","volume":"3","author":"Lee","year":"2018","journal-title":"ACS Omega"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1039\/C6BM00179C","article-title":"A Glycosaminoglycan Mimetic Peptide Nanofiber Gel as an Osteoinductive Scaffold","volume":"4","author":"Tansik","year":"2016","journal-title":"Biomater. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1021\/jacsau.2c00537","article-title":"Design and Synthesis of Neutralizable Fondaparinux","volume":"2","author":"Zhang","year":"2022","journal-title":"JACS Au"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(03)00030-6","article-title":"Evaluation of the Pharmacological Properties and Clinical Results of the Synthetic Pentasaccharide (Fondaparinux)","volume":"109","author":"Samama","year":"2003","journal-title":"Thromb. Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1055\/s-2007-982088","article-title":"PI-88 and Novel Heparan Sulfate Mimetics Inhibit Angiogenesis","volume":"33","author":"Ferro","year":"2007","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1172\/JCI76566","article-title":"Heparan Sulfate Mimetic PG545-Mediated Antilymphoma Effects Require TLR9-Dependent NK Cell Activation","volume":"126","author":"Brennan","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/978-3-030-34521-1_18","article-title":"Immunomodulatory Activities of the Heparan Sulfate Mimetic PG545","volume":"1221","author":"Bendersky","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.matbio.2018.08.005","article-title":"The Heparanase Inhibitor PG545 Is a Potent Anti-Lymphoma Drug: Mode of Action","volume":"77","author":"Weissmann","year":"2019","journal-title":"Matrix Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/aos.13116","article-title":"RGTA in Corneal Wound Healing after Transepithelial Laser Ablation in a Rabbit Model: A Randomized, Blinded, Placebo-Controlled Study","volume":"94","author":"Xeroudaki","year":"2016","journal-title":"Acta Ophthalmol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.juro.2014.09.036","article-title":"Pentosan Polysulfate Sodium for Treatment of Interstitial Cystitis\/Bladder Pain Syndrome: Insights from a Randomized, Double-Blind, Placebo Controlled Study","volume":"193","author":"Nickel","year":"2015","journal-title":"J. Urol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1080\/03007995.2019.1586401","article-title":"Efficacy of Pentosan Polysulfate for the Treatment of Interstitial Cystitis\/Bladder Pain Syndrome: Results of a Systematic Review of Randomized Controlled Trials","volume":"35","author":"Vonde","year":"2019","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.3324\/haematol.2017.182865","article-title":"Phase I Study of the Heparanase Inhibitor Roneparstat: An Innovative Approach for Ultiple Myeloma Therapy","volume":"103","author":"Galli","year":"2018","journal-title":"Haematologica"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1634\/theoncologist.2017-0472","article-title":"Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of Necuparanib Combined with Nab-Paclitaxel and Gemcitabine in Patients with Metastatic Pancreatic Cancer: Phase I Results","volume":"22","author":"Roach","year":"2017","journal-title":"Oncologist"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3026(21)00053-3","article-title":"Sevuparin for the Treatment of Acute Pain Crisis in Patients with Sickle Cell Disease: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial","volume":"8","author":"Biemond","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"484","DOI":"10.12688\/wellcomeopenres.20111.2","article-title":"SEVUparin as a Potential Adjunctive Treatment in Children with Severe Malaria: A Phase I Trial Safety and Dose Finding Trial (SEVUSMAART)","volume":"8","author":"Maitland","year":"2024","journal-title":"Wellcome Open Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated Heparin Associated with Adverse Clinical Events and Activation of the Contact System","volume":"358","author":"Kishimoto","year":"2008","journal-title":"New Engl. J. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1056\/NEJMoa0806450","article-title":"Outbreak of Adverse Reactions Associated with Contaminated Heparin","volume":"359","author":"Blossom","year":"2008","journal-title":"New Engl. J. Med."},{"key":"ref_110","first-page":"4342","article-title":"Collagen\/Hyaluronan Based Hydrogels Releasing Sulfated Hyaluronan Improve Dermal Wound Healing in Diabetic Mice via Reducing Inflammatory Macrophage Activity","volume":"6","author":"Hauck","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"5621","DOI":"10.1016\/j.actbio.2012.11.016","article-title":"Artificial Extracellular Matrices Composed of Collagen i and High-Sulfated Hyaluronan Promote Phenotypic and Functional Modulation of Human pro-Inflammatory M1 Macrophages","volume":"9","author":"Franz","year":"2013","journal-title":"Acta Biomater."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1700082","DOI":"10.1002\/pmic.201700082","article-title":"Sulfated Hyaluronan Attenuates Inflammatory Signaling Pathways in Macrophages Involving Induction of Antioxidants","volume":"17","author":"Jouy","year":"2017","journal-title":"Proteomics"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40425-018-0363-5","article-title":"Immunomodulatory Activities of Pixatimod: Emerging Nonclinical and Clinical Data, and Its Potential Utility in Combination with PD-1 Inhibitors","volume":"6","author":"Hammond","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_114","first-page":"75","article-title":"RGTA OTR4120, a Heparan Sulfate Mimetic, Is a Possible Long-Term Active Agent to Heal Burned Skin","volume":"80","author":"Alexakis","year":"2007","journal-title":"J. Biomed. Mater. Res. A"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/PRS.0b013e318200a910","article-title":"Matrix Therapy with RGTA OTR4120 Improves Healing Time and Quality in Hairless Rats with Deep Second-Degree Burns","volume":"127","author":"Zakine","year":"2011","journal-title":"Plast. Reconstr. Surg."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/11\/1518\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T05:17:28Z","timestamp":1761715048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/15\/11\/1518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":115,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["biom15111518"],"URL":"https:\/\/doi.org\/10.3390\/biom15111518","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}